hims personalized semaglutide Just Launched an Ozempic Dupe Hims is in the crosshairs.

The Verdict: Very limited human data

Nicolau, P

Proven Cardiovascular Benefits Reduced major adverse cardiovascular events (MACE) Reduced heart failure risk Anti-atherosclerotic effects Blood pressure reduction Weight-mediated cardiometabolic improvement Semaglutide and liraglutide especially demonstrated major cardiovascular outcome benefits

Additional information about locating and reviewing product documentation is available on the Nordexa Certificates of Analysis page

Any reliance on the information in this article is at the reader's own risk

Long-term Effects : More extensive longitudinal studies are necessary to thoroughly understand long-term safety implications